Bing Center for Waldenstrom's Macroglobulinemia - Histone Deacetylase Inhibitors Demonstrate Significant Preclinical Activity as Single Agents, and in Combination with Bortezomib in Waldenstrom's Macroglobulinemia

You are here: Home

Pubs

Pub-2011

Histone Deacetylase Inhibitors Demonstrate Significant Preclinical Activity as Single Agents, and in Combination with Bortezomib in Waldenstrom's Macroglobulinemia

Can't see this document? Click Here

Legal | Privacy